C.M. Bidwell & Associates’s Progyny PGNY Stock Holding History

C.M. Bidwell & Associates’s Portfolio PGNY Stock Details PGNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-920	Closed	-$35.1K	–	519
2024 Q1	$35.1K	Sell	920 -5	-0.5%	-$189	0.02%	246
2023 Q4	$34.4K	Sell	925 -3,343	-78%	-$112K	0.03%	248
2023 Q3	$145K	Sell	4,268 -61	-1%	-$2.3K	0.11%	155
2023 Q2	$170K	Buy	+4,329	New	+$156K	0.12%	143

Other funds holding PGNY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ONPI

Owls Nest Partners IA Chadds Ford, Pennsylvania $286M AUM 16.4% 1-Year Est. Return

C.M. Bidwell & Associates's PGNY Position: Q2 2024 in Review

C.M. Bidwell & Associates sold out of Progyny (PGNY) in Q2 2024, closing a stake of 920 shares — an estimated $35.1K sold.

C.M. Bidwell & Associates first reported a position in PGNY in Q2 2023 and held it in 4 quarters. The position peaked at $170K in Q2 2023. 324 funds tracked by Wall St. Rank hold PGNY as of Q2 2024.

C.M. Bidwell & Associates reported no remaining Progyny position as of Q2 2024 after selling out during the quarter.
C.M. Bidwell & Associates sold 920 Progyny shares in Q2 2024, an estimated $35.1K.
C.M. Bidwell & Associates first reported a position in Progyny in Q2 2023 and held it in 4 quarters.
C.M. Bidwell & Associates's Progyny position peaked at $170K in Q2 2023.
324 funds tracked by Wall St. Rank held Progyny as of Q2 2024.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2024, filed 13 Aug 2024.